Skip to main content
. Author manuscript; available in PMC: 2021 Jul 13.
Published in final edited form as: Urology. 2020 Jul 25;144:111–116. doi: 10.1016/j.urology.2020.07.027

Figure 4.

Figure 4.

RTK/RAS/MAPK pathway alterations in KIT-mutant germ-cell tumors. The values shown represent the percentage of KIT-mutant samples (n = 46) with oncogenic alterations in the listed genes.